• Trials and Research

  Study Says Ocrevus Depletes Certain T-cells in MS Patients

  Posted by MS News Today Moderator on January 23, 2019 at 11:40 am

  

  A single dose of Ocrevus (ocrelizumab) depleted immune T-cells within two weeks in patients with relapsing and primary progressive MS, a study shows. Click here to read more about this study and its findings.

  What do you think about this study and its findings? Does this news impact your opinion on Ocrevus?

  replied 5 years, 3 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply